A new study of patients at an urban cancer center points to a potentially serious problem that may limit the impact of clinical cancer care—undiagnosed depression.
A new study involving patients with stage IV cancer finds that treatment with radiation therapy and immunotherapy can halt the growth of tumors by stimulating the body’s immune system to attack the cancer.
Combining radiation therapy with chemotherapy for patients with limited metastatic non-small cell lung cancer (NSCLC) may curb disease progression dramatically when compared to NSCLC patients who only receive chemotherapy, according to a new randomized phase II clinical trial reported today at the 59th Annual Meeting of the American Society for Radiation Oncology (ASTRO).
Long-term results of a phase III clinical trial indicate that survival rates for patients receiving chemoradiation for unresectable, locally advanced non-small cell lung cancer (NSCLC) may be more than twice as high as previous estimates.
Findings from a new multicenter, international clinical trial confirm the effectiveness of high-dose brachytherapy, or internal radiation therapy, for managing locally advanced cervical cancer. Tumor control was significantly better following four fractions of 7 Gray (Gy) each than following two, 9-Gy fractions of high-dose-rate (HDR) brachytherapy, but neither overall survival nor severe treatment-related side effects differed between the treatment groups.
The American Society for Radiation Oncology (ASTRO) is awarding $275,000 in research awards to four early-career scientists as part of the Society’s efforts to retain and foster the intellectual research talent currently entering the field of radiation oncology.
The press program for the 2017 Annual Meeting of the American Society for Radiation Oncology (ASTRO) will feature advances in cancer research, including reports from phase II and III clinical trials. Studies that examine innovative treatments, such as immunotherapy, mental health influences on cancer outcomes and optimal radiation dosing and sequencing, will also be presented at the largest meeting for the field of radiation oncology.
The Radiation Oncology Institute (ROI) announced today the winners of its inaugural publication awards, which recognize research on the value of radiation therapy for improving cancer outcomes.
The American Society for Radiation Oncology (ASTRO) applauds the United States Nuclear Regulatory Commission (NRC) for today’s announcement of a final rule that updates the definition of medical events for permanent implant brachytherapy and protects patients’ access to this treatment.
The American Society for Radiation Oncology (ASTRO) recently welcomed Margarita Valdez as its assistant director of congressional relations, a key position on its government relations and advocacy team.
Advances in Radiation Oncology, the newest journal of the American Society for Radiation Oncology (ASTRO), is now indexed by PubMed Central, a free, full-text archive of biomedical and life sciences literature organized by the U.S. National Institutes of Health (NIH)’s National Library of Medicine.
The American Society for Radiation Oncology has selected 23 distinguished members to receive the ASTRO Fellow designation. The 2017 class of Fellows will be recognized during the Awards Ceremony at ASTRO’s 59th Annual Meeting, to be held September 24-27 in San Diego.
Edith Peterson Mitchell, MD, a leading researcher, medical oncologist and proponent of combined modality treatment, has been chosen as the 2017 American Society for Radiation Oncology (ASTRO) Honorary Member.
The members of the American Society for Radiation Oncology (ASTRO) have elected a new President-elect, Health Policy Council Vice-chair and Science Council Vice-chair to ASTRO’s Board of Directors and three members to serve on the medical society’s Nominating Committee.
The winner of the American Society for Radiation Oncology’s (ASTRO’s) 2017 Survivor Circle Award is many things—a former pro baseball player, a retired UPS driver, a family man and, yes, a current cancer patient.
The American Society for Radiation Oncology (ASTRO) has issued an update to its recommendations for medical insurance coverage regarding the use of proton beam therapy to treat cancer. The updated Proton Beam Therapy Model Policy provides guidance to payers on clinical indications that are appropriate for treatment with proton therapy and should be covered by health insurance.
The American Society for Radiation Oncology (ASTRO) will award its annual Survivor Circle grants to two San Diego-based cancer support charities: Cancer Angels of San Diego and The Seany Foundation. Each organization will receive an $8,500 grant to support their programs for those who have been affected by cancer and will be recognized during ASTRO’s Annual Meeting, September 24-27, in San Diego.
The Chair of the American Society for Radiation Oncology (ASTRO) David C. Beyer, MD, FASTRO, issued the following statement opposing Senate Republicans’ discussion draft of the American Health Care Act (AHCA) released today:
In response to an aging U.S. population and the rise in cancer incidence rates, a new special edition of the International Journal of Radiation Oncology•Biology•Physics (Red Journal) explores trends, challenges and new approaches in treating cancer in elderly patients with radiation therapy.
The American Society for Radiation Oncology (ASTRO) issued a new clinical guideline for the use of stereotactic body radiation therapy (SBRT) in early-stage lung cancer today.
A meta-analysis of previously published cancer research showed no difference in five-year and 10-year survival rates between patients who underwent radical cystectomy, which is the surgical removal of the bladder, and a bladder-preserving combined modality treatment (CMT) plan, which combines radiation therapy, chemotherapy and the removal of the bladder tumor.
The American Society for Radiation Oncology (ASTRO) strongly opposes the extensive cuts to cancer research and Medicaid funding in the Fiscal Year 2018 budget released today by the White House.
Registration opens today for the 59th Annual Meeting of the American Society for Radiation Oncology (ASTRO), which will highlight advances in cancer research and clinical care involving radiation therapy, also known as radiotherapy.
More than 100 radiation oncologists from across the United States are on Capitol Hill urging Congress to grow its investment in cancer research and to protect patients’ access to high quality cancer care.
Cancer patients who speak Spanish have new tools to help them understand treatment options for their disease. The American Society for Radiation Oncology (ASTRO) today released a series of Spanish-language patient videos on radiation therapy for cancer, including breast, prostate, lung, brain and other common cancer types. The videos complement a set of Spanish-language brochures on radiation therapy that ASTRO released earlier this year.
The American Society for Radiation Oncology (ASTRO) encourages cancer survivors in or around San Diego to apply for its Survivor Circle Award, an annual honor that recognizes an individual for translating their diagnosis into a commitment to helping others through cancer-related volunteering and service.
Patients in their 80s and 90s who have early stage lung cancer but cannot undergo an operation can be treated safely and effectively with stereotactic body radiation therapy (SBRT), according to research presented today at the 2017 Multidisciplinary Thoracic Cancers Symposium.
An emerging approach for cancer treatment seeks to combine radiation therapy with immune checkpoint inhibitors (ICPIs) to more effectively control tumors in the chest with an acceptable risk of severe treatment-related side effects.
Results from a prospective clinical trial showed that a blood test looking at specific biomarkers was able to detect recurrences of lung cancer an average of six months before conventional imaging methods found evidence of recurrence.
Analysis of the largest American cancer database indicates that racial disparities persist in the treatment and outcomes of patients diagnosed with stage I non-small cell lung cancer (NSCLC).
The press program for next week’s 2017 Multidisciplinary Thoracic Cancers Symposium features research advances in lung cancer including immunotherapy, proton therapy and liquid biopsy, among others.
Results from a new prospective clinical trial indicate that high-dose-rate (HDR) brachytherapy administered in a single, 19 Gray (Gy) treatment may be a safe and effective alternative to longer courses of HDR treatment for men with localized prostate cancer.
CancerLinQ LLC and the American Society for Radiation Oncology (ASTRO) are partnering to bring radiation oncology expertise to CancerLinQ and improve the care of cancer patients nationwide.
The 2017 Multidisciplinary Thoracic Cancers Symposium, co-sponsored by the American Society for Radiation Oncology (ASTRO), the American Society of Clinical Oncology (ASCO) and The Society of Thoracic Surgeons (STS), will feature advances in surgery, radiation therapy, chemotherapy and novel molecular biologic therapies for thoracic malignancies such as lung cancer.
The American Society for Radiation Oncology (ASTRO) recently published an updated clinical guideline that underscores the safety and effectiveness of palliative radiation therapy (RT) for treating painful bone metastases.
As the new Congress and administration wrestle with policy decisions on the provision of high quality, affordable health coverage, the American Society for Radiation Oncology (ASTRO) urges policymakers to prioritize reforms that avoid disruption in coverage and care.
As the world's leading organizations representing laboratory researchers, physician-scientists, clinicians, the nation’s cancer centers, and patient advocates committed to improved care for patients with cancer and blood diseases, we express our deep concern about the Administration’s executive order that has denied U.S. entry to people who bring unique expertise to the practice of medicine and the conduct of cancer and biomedical research.
The American Society for Radiation Oncology (ASTRO) today expressed strong support for the nomination of David Shulkin, MD, as Secretary of the Department of Veterans Affairs (VA).
The American Society for Radiation Oncology (ASTRO) today expressed its support for the nominations of Tom Price, MD, as Health and Human Services (HHS) Department Secretary and Seema Verma as Centers for Medicare and Medicaid Services (CMS) Administrator.
The American Society for Radiation Oncology (ASTRO) today issued an updated clinical practice statement for accelerated partial breast irradiation (APBI) for early-stage breast cancer.
The Radiation Oncology Institute (ROI) invites researchers to submit their work for its inaugural publication awards, which will recognize studies focused on the comparative value of radiation therapy (RT) in an effort to improve cancer outcomes while slowing the growth of health care spending.
Leadership from the American Society for Radiation Oncology (ASTRO) participated in an event at the White House yesterday hosted by Vice President Joe Biden, who released a report outlining the Cancer Moonshot Initiative’s (CMI) progress to date and roadmap for its four remaining years.